Form 4: NEXGEL CEO Sells Shares Under 10b5-1 Plan

NEXGEL CEO Adam R. Levy sold 4,000 shares of common stock in early October 2025 through a pre-arranged 10b5-1 trading plan for tax planning purposes.

Summary

• Adam R. Levy, Chief Executive Officer and Director of NEXGEL, INC. (NXGL), reported the sale of common stock.
• The sales were executed pursuant to a Rule 10b5-1 trading plan, which was instituted for tax planning purposes.
• On October 2, 2025, 1,600 shares of common stock were sold at a price of $2.50 per share.
• On October 3, 2025, an additional 2,400 shares of common stock were sold at a weighted average price of $2.5497 per share, with individual transaction prices ranging from $2.500 to $2.6100.
• Following these reported transactions, Adam R. Levy directly beneficially owns 371,692 shares of NEXGEL common stock.
• The shares sold were originally acquired by Adam R. Levy from NEXGEL on October 15, 2019.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan for tax planning, which is generally considered a neutral event and does not reflect on the company's operational performance or future prospects.

Management Comments

• The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes.

Industry Context

This filing reports a company-specific insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders may observe insider selling, but the explicit mention of a 10b5-1 plan for tax purposes mitigates potential negative interpretations. The total shares sold represent a small fraction of the CEO's overall holdings.

Key Dates

Keywords

NEXGEL, NXGL, Adam R. Levy, CEO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Tax Planning, Common Stock